首页 > 最新文献

European Journal of Surgery最新文献

英文 中文
A survey of surgical treatment of gallstone disease and the diffusion of laparoscopic surgery in Sweden 1992–93 1992 - 1993年瑞典胆结石手术治疗及腹腔镜手术普及情况的调查
European Journal of Surgery
Pub Date : 2003-12-02 DOI: 10.1080/110241598750004526
Ulf Berggren, Dag Arvidsson, Ulf Haglund

Objective:

To study the diffusion of laparoscopic biliary surgery in Sweden, 1992–93.

Design:

A prospective survey of all biliary surgery for gallstone disease recorded for 8 weeks in 1992 and the same period in 1993.

Setting:

All surgical departments in Sweden.

Subjects:

A consecutive series of 1938 patients in 1992 and 1748 patients in 1993.

Main outcome measures:

The changing indications, diffusion, morbidity, mortality, postoperative and hospital stay after laparoscopic cholecystectomy (LC) in Sweden in 1992 compared with 1993.

Results:

Despite the spread of LC, the indications did not change between 1992 and 1993 (p = 0.31). The total number of cholecystectomies decreased from 1938 in 1992 to 1748 in 1993. The overall percentage of laparoscopic cholecystectomies (LCs) increased from 74.7% to 81.2% (p < 0.001) between 1992 and 1993.

Postoperative morbidity and mortality after LC did not differ between 1992 and 1993, but the total morbidity was 9.0% in 1992 and 7.0% in 1993 (p = 0.02). Mortality for all cholecystectomies did not change over the periods, being 0.6% in 1992 and 0.2% in 1993 (p = 0.07). The numbers of LCs done in any hospital were divided in two groups, 20 or fewer and 21–80. In the smaller group, the postoperative morbidity was 7.1% and in the larger group it was 7.0%, (p = 0.9). The postoperative mortality was 0.1% in both groups.

The postoperative and total hospital stays of all cholecystectomies decreased from 3.4 days in 1992 to 2.9 days in 1993 (p = 0.001) and from 5.0 in 1992 to 4.4 days in 1993 (p < 0.001), respectively. The postoperative and total hospital stays of LCs decreased from 2.0 in 1992 to 1.8 days in 1993 (p = 0.009) and from 3.3 in 1992 to 2.9 days in 1993 (p = 0.007), respectively.

Conclusion:

Despite the introduction and diffusion of the new technology, LC, the indications for surgery did not change and the number of cholecystectomies did not increase from 1992 to 1993. The morbidity and mortality of LC and the mortality of all cholecystectomies were unchanged b

目的:探讨1992 - 1993年瑞典腹腔镜胆道手术的扩散情况。设计:对1992年和1993年同期所有胆道手术患者进行为期8周的前瞻性调查。地点:瑞典所有外科部门。研究对象:1992年1938例，1993年1748例。主要观察指标:1992年与1993年相比，瑞典腹腔镜胆囊切除术(LC)的适应症、扩散、发病率、死亡率、术后和住院时间的变化。结果:1992 - 1993年间，尽管LC的扩散，但适应症没有变化(p = 0.31)。胆囊切除术的总数从1992年的1938例下降到1993年的1748例。腹腔镜胆囊切除术(lc)的总比例从74.7%上升到81.2% (p <0.001)。1992年和1993年LC术后发病率和死亡率无差异，但1992年和1993年的总发病率分别为9.0%和7.0% (p = 0.02)。所有胆囊切除术的死亡率在不同时期没有变化，1992年为0.6%，1993年为0.2% (p = 0.07)。在任何一家医院完成的lc数量分为两组，20或更少和21-80。小组术后发病率为7.1%，大组为7.0%，差异有统计学意义(p = 0.9)。两组术后死亡率均为0.1%。所有胆囊切除术的术后住院时间和总住院时间从1992年的3.4天减少到1993年的2.9天(p = 0.001)，从1992年的5.0天减少到1993年的4.4天(p <分别为0.001)。术后总住院时间由1992年的2.0天减少到1993年的1.8天(p = 0.009)，由1992年的3.3天减少到1993年的2.9天(p = 0.007)。结论:1992 - 1993年，尽管胆囊切除术新技术的引进和推广，但手术适应证没有改变，胆囊切除术的数量没有增加。1992年至1993年，LC的发病率和死亡率以及所有胆囊切除术的死亡率没有变化，但所有胆囊切除术的发病率下降。在任何一家医院进行的LC或全部胆囊切除术的数量与发病率或死亡率无关。版权所有©1998 Taylor and Francis Ltd。
{"title":"A survey of surgical treatment of gallstone disease and the diffusion of laparoscopic surgery in Sweden 1992–93","authors":"Ulf Berggren,&nbsp;Dag Arvidsson,&nbsp;Ulf Haglund","doi":"10.1080/110241598750004526","DOIUrl":"10.1080/110241598750004526","url":null,"abstract":"<div>\u0000 \u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective:</h3>\u0000 \u0000 <p>To study the diffusion of laparoscopic biliary surgery in Sweden, 1992–93.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design:</h3>\u0000 \u0000 <p>A prospective survey of all biliary surgery for gallstone disease recorded for 8 weeks in 1992 and the same period in 1993.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting:</h3>\u0000 \u0000 <p>All surgical departments in Sweden.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Subjects:</h3>\u0000 \u0000 <p>A consecutive series of 1938 patients in 1992 and 1748 patients in 1993.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main outcome measures:</h3>\u0000 \u0000 <p>The changing indications, diffusion, morbidity, mortality, postoperative and hospital stay after laparoscopic cholecystectomy (LC) in Sweden in 1992 compared with 1993.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results:</h3>\u0000 \u0000 <p>Despite the spread of LC, the indications did not change between 1992 and 1993 (<i>p</i> = 0.31). The total number of cholecystectomies decreased from 1938 in 1992 to 1748 in 1993. The overall percentage of laparoscopic cholecystectomies (LCs) increased from 74.7% to 81.2% (<i>p</i> &lt; 0.001) between 1992 and 1993.</p>\u0000 \u0000 <p>Postoperative morbidity and mortality after LC did not differ between 1992 and 1993, but the total morbidity was 9.0% in 1992 and 7.0% in 1993 (<i>p</i> = 0.02). Mortality for all cholecystectomies did not change over the periods, being 0.6% in 1992 and 0.2% in 1993 (<i>p</i> = 0.07). The numbers of LCs done in any hospital were divided in two groups, 20 or fewer and 21–80. In the smaller group, the postoperative morbidity was 7.1% and in the larger group it was 7.0%, (<i>p</i> = 0.9). The postoperative mortality was 0.1% in both groups.</p>\u0000 \u0000 <p>The postoperative and total hospital stays of all cholecystectomies decreased from 3.4 days in 1992 to 2.9 days in 1993 (<i>p</i> = 0.001) and from 5.0 in 1992 to 4.4 days in 1993 (<i>p</i> &lt; 0.001), respectively. The postoperative and total hospital stays of LCs decreased from 2.0 in 1992 to 1.8 days in 1993 (<i>p</i> = 0.009) and from 3.3 in 1992 to 2.9 days in 1993 (<i>p</i> = 0.007), respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion:</h3>\u0000 \u0000 <p>Despite the introduction and diffusion of the new technology, LC, the indications for surgery did not change and the number of cholecystectomies did not increase from 1992 to 1993. The morbidity and mortality of LC and the mortality of all cholecystectomies were unchanged b","PeriodicalId":100508,"journal":{"name":"European Journal of Surgery","volume":"164 4","pages":"287-295"},"PeriodicalIF":0.0,"publicationDate":"2003-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241598750004526","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20559651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
An experimental study on effects of monopolar diathermy on the bile ducts 单极透热对胆管影响的实验研究
European Journal of Surgery
Pub Date : 2003-12-02 DOI: 10.1080/110241598750004535
Erik Trondsen, Arne R. Rosseland, Arne Bakka, Tom Erik Ruud, Tormod Martinsen, Ole P. F. Clausen, Anstein Bergan, Ansgar O. Aasen

Objective:

To study the effects of monopolar diathermy on the bile ducts in pigs.

Design:

Experimental study.

Setting:

University hospital, Norway.

Material:

18 pigs.

Interventions:

Laparotomy, application of diathermy at standard sites along the cystic duct, the bile ducts, and a cystic duct containing a metal clip, 3 to 12 times of 5 seconds' duration at each site. Temperature was subsequently recorded at standard measurement points on the bile ducts. Twelve pigs were killed after three weeks for assessment of the bile ducts at necropsy.

Main outcome measurements:

Increase in temperature in the bile duct walls and late changes in the bile ducts.

Results:

Temperature increased by 4–6°C during 6 of 330 diathermy applications along the cystic duct, by 4–18°C in 8 of 126 applications along the common bile duct, and by 4–11°C at the clip in 9 of 54 applications. There were no macroscopic or microscopic changes in the bile ducts.

Conclusion:

Monopolar diathermy induced unexpected distant increases in the temperature of the bile duct walls and at a clip on the cystic duct probably because diathermy current energy was distributed along channels of high current conductivity. Copyright © 1998 Taylor and Francis Ltd.

目的:研究单极透热对猪胆管的影响。设计:实验研究。地点:挪威大学医院。材料:18头猪。干预措施:开腹手术，沿胆囊管、胆管和含金属夹的胆囊管标准部位进行透热治疗，每次5秒，每次3 - 12次。随后在胆管上的标准测量点记录温度。12头猪在三周后被杀死，以在尸检中评估胆管。主要观察指标:胆管壁温度升高和胆管晚期变化。结果:330例沿胆囊管热疗中6例温度升高4-6°C, 126例沿胆总管热疗中8例温度升高4-18°C, 54例中9例温度升高4-11°C。胆管未见宏观或微观改变。结论:单极透热可引起胆管壁远端温度升高，可能是由于透热电流能量沿高电流传导通道分布。版权所有©1998 Taylor and Francis Ltd。
{"title":"An experimental study on effects of monopolar diathermy on the bile ducts","authors":"Erik Trondsen,&nbsp;Arne R. Rosseland,&nbsp;Arne Bakka,&nbsp;Tom Erik Ruud,&nbsp;Tormod Martinsen,&nbsp;Ole P. F. Clausen,&nbsp;Anstein Bergan,&nbsp;Ansgar O. Aasen","doi":"10.1080/110241598750004535","DOIUrl":"10.1080/110241598750004535","url":null,"abstract":"<div>\u0000 \u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective:</h3>\u0000 \u0000 <p>To study the effects of monopolar diathermy on the bile ducts in pigs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design:</h3>\u0000 \u0000 <p>Experimental study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting:</h3>\u0000 \u0000 <p>University hospital, Norway.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Material:</h3>\u0000 \u0000 <p>18 pigs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interventions:</h3>\u0000 \u0000 <p>Laparotomy, application of diathermy at standard sites along the cystic duct, the bile ducts, and a cystic duct containing a metal clip, 3 to 12 times of 5 seconds' duration at each site. Temperature was subsequently recorded at standard measurement points on the bile ducts. Twelve pigs were killed after three weeks for assessment of the bile ducts at necropsy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main outcome measurements:</h3>\u0000 \u0000 <p>Increase in temperature in the bile duct walls and late changes in the bile ducts.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results:</h3>\u0000 \u0000 <p>Temperature increased by 4–6°C during 6 of 330 diathermy applications along the cystic duct, by 4–18°C in 8 of 126 applications along the common bile duct, and by 4–11°C at the clip in 9 of 54 applications. There were no macroscopic or microscopic changes in the bile ducts.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion:</h3>\u0000 \u0000 <p>Monopolar diathermy induced unexpected distant increases in the temperature of the bile duct walls and at a clip on the cystic duct probably because diathermy current energy was distributed along channels of high current conductivity. Copyright © 1998 Taylor and Francis Ltd.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100508,"journal":{"name":"European Journal of Surgery","volume":"164 4","pages":"297-303"},"PeriodicalIF":0.0,"publicationDate":"2003-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241598750004535","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20559652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Screening of concentrations of C-reactive protein and various plasma protease inhibitors preoperatively for the prediction of postoperative complications 术前筛查c反应蛋白及各种血浆蛋白酶抑制剂浓度预测术后并发症
European Journal of Surgery
Pub Date : 2003-12-02 DOI: 10.1080/110241598750004733
Joakim Göransson, Svante Jonsson, Åke Lasson

Objective:

To find out whether concentrations of albumin (reflecting nutritional state), C-reactive protein (reflecting an acute phase reaction) or plasma protease inhibitors (reflecting ongoing proteolysis) are good predictors of postoperative complications, and whether other biochemical tests may improve diagnostic accuracy.

Design:

Retrospective study.

Setting:

University hospital, Sweden.

Subjects:

260 patients undergoing elective surgery for malignant (n = 149) or benign (n = 111) disease.

Main outcome measures:

Preoperative biochemical plasma measurements and postoperative complications.

Results:

192 patients recovered uneventfully and 35 had minor and 33 major postoperative complications. An increased plasma C-reactive protein concentration preoperatively, as well as a reduced albumin concentration, predicted the risk of developing major postoperative complications. Measurement of plasma protease inhibitors (C1-esterase inhibitor, alpha-2-macroglobulin and antithrombin III), specific biochemical studies of microheterogeneity, or comparison of quantitative and functional concentrations of the inhibitors gave no additional information.

Conclusion:

One measurement of the C-reactive protein and albumin concentrations preoperatively will identify patients at risk of developing severe postoperative complications. Copyright © 1998 Taylor and Francis Ltd.

目的:了解白蛋白(反映营养状况)、c反应蛋白(反映急性期反应)或血浆蛋白酶抑制剂(反映正在进行的蛋白水解)的浓度是否能很好地预测术后并发症，以及其他生化检查是否可以提高诊断的准确性。设计:回顾性研究。地点:瑞典大学医院。对象:260例因恶性(149例)或良性(111例)疾病接受择期手术的患者。主要观察指标:术前血浆生化指标及术后并发症。结果:192例患者术后恢复平稳，35例发生轻微并发症，33例发生严重并发症。术前血浆c反应蛋白浓度升高，白蛋白浓度降低，可预测发生术后主要并发症的风险。血浆蛋白酶抑制剂(c1 -酯酶抑制剂、α -2巨球蛋白和抗凝血酶III)的测量、微观异质性的特定生化研究或抑制剂的定量和功能浓度的比较没有提供额外的信息。结论:术前c反应蛋白和白蛋白浓度的测量可以识别患者是否有发生严重术后并发症的风险。版权所有©1998 Taylor and Francis Ltd。
{"title":"Screening of concentrations of C-reactive protein and various plasma protease inhibitors preoperatively for the prediction of postoperative complications","authors":"Joakim Göransson,&nbsp;Svante Jonsson,&nbsp;Åke Lasson","doi":"10.1080/110241598750004733","DOIUrl":"10.1080/110241598750004733","url":null,"abstract":"<div>\u0000 \u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective:</h3>\u0000 \u0000 <p>To find out whether concentrations of albumin (reflecting nutritional state), C-reactive protein (reflecting an acute phase reaction) or plasma protease inhibitors (reflecting ongoing proteolysis) are good predictors of postoperative complications, and whether other biochemical tests may improve diagnostic accuracy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design:</h3>\u0000 \u0000 <p>Retrospective study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting:</h3>\u0000 \u0000 <p>University hospital, Sweden.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Subjects:</h3>\u0000 \u0000 <p>260 patients undergoing elective surgery for malignant (<i>n</i> = 149) or benign (<i>n</i> = 111) disease.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main outcome measures:</h3>\u0000 \u0000 <p>Preoperative biochemical plasma measurements and postoperative complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results:</h3>\u0000 \u0000 <p>192 patients recovered uneventfully and 35 had minor and 33 major postoperative complications. An increased plasma C-reactive protein concentration preoperatively, as well as a reduced albumin concentration, predicted the risk of developing major postoperative complications. Measurement of plasma protease inhibitors (C1-esterase inhibitor, alpha-2-macroglobulin and antithrombin III), specific biochemical studies of microheterogeneity, or comparison of quantitative and functional concentrations of the inhibitors gave no additional information.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion:</h3>\u0000 \u0000 <p>One measurement of the C-reactive protein and albumin concentrations preoperatively will identify patients at risk of developing severe postoperative complications. Copyright © 1998 Taylor and Francis Ltd.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100508,"journal":{"name":"European Journal of Surgery","volume":"164 2","pages":"89-101"},"PeriodicalIF":0.0,"publicationDate":"2003-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241598750004733","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20459730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Use of desmopressin to prevent bleeding in surgery 去氨加压素在手术中预防出血的应用
European Journal of Surgery
Pub Date : 2003-12-02 DOI: 10.1080/110241598750004887
Per Anders Flordal
{"title":"Use of desmopressin to prevent bleeding in surgery","authors":"Per Anders Flordal","doi":"10.1080/110241598750004887","DOIUrl":"10.1080/110241598750004887","url":null,"abstract":"","PeriodicalId":100508,"journal":{"name":"European Journal of Surgery","volume":"164 1","pages":"5-11"},"PeriodicalIF":0.0,"publicationDate":"2003-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241598750004887","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20462402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
Surgical treatment of chronic critical leg ischaemia 慢性重症下肢缺血的外科治疗
European Journal of Surgery
Pub Date : 2003-12-02 DOI: 10.1080/110241598750004931
M. Luther

Objective:

To evaluate mobility and care level required after amputation and arterial reconstruction for chronic critical leg ischaemia.

Design:

A 5 year follow up study in three hospitals serving a defined population.

Setting:

One regional and two district hospitals, Finland.

Patients:

117 Consecutive patients.

Outcome measures:

Survival, amputations, mobility, and care level required.

Main results:

66 Primary reconstructions, 51 primary and 35 later major amputations were done. Preoperatively 27 (53%) of the patients who underwent a primary amputation were in permanent institutional care. Of 86 patients who were living outside an institution, 62 (72%) had a reconstruction. One and five year mortality were 43% and 84% after amputation, and 20% and 57% after reconstruction, respectively. Of the patients who had had an amputation 10% were able to walk and 25% could manage to live outside an institution. Mobility and treatment level after primary and secondary amputations were similar. Forty seven (71%) of the patients who had had a reconstruction did not have an amputation. All patients whose reconstructions were successful preserved their walking ability and independent living.

Conclusion:

To maintain mobility and an independent living in patients with chronic critical leg ischaemia it is necessary to do a reconstruction that can salvage the leg. In old, institutionalised patients chronic critical leg ischaemia is often the harbinger of approaching death and then amputation is the only possible solution. Copyright © 1998 Taylor and Francis Ltd.

目的:评价慢性重症下肢缺血截肢及动脉重建术后的活动能力及护理水平。设计:一项为期5年的随访研究，在三家医院为特定人群服务。环境:芬兰，一所地区医院和两所地区医院。患者:117例连续患者。结局指标:生存、截肢、活动能力和所需护理水平。主要结果:一期重建66例，一期51例，后期大截肢35例。术前27例(53%)接受原发性截肢的患者在永久性机构护理中。在86名住在医疗机构外的患者中，62名(72%)进行了重建。截肢后1年和5年死亡率分别为43%和84%，重建后分别为20%和57%。在截肢的患者中，10%的人能够行走，25%的人能够在医疗机构外生活。原发性和继发性截肢术后的活动能力和治疗水平相似。47例(71%)接受重建的患者没有截肢。所有重建成功的患者均保留了行走能力和独立生活。结论:为维持慢性重症下肢缺血患者的活动能力和独立生活，有必要进行修复性下肢重建。在老年住院病人中，慢性严重腿部缺血往往是接近死亡的预兆，然后截肢是唯一可能的解决方案。版权所有©1998 Taylor and Francis Ltd。
{"title":"Surgical treatment of chronic critical leg ischaemia","authors":"M. Luther","doi":"10.1080/110241598750004931","DOIUrl":"10.1080/110241598750004931","url":null,"abstract":"<div>\u0000 \u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective:</h3>\u0000 \u0000 <p>To evaluate mobility and care level required after amputation and arterial reconstruction for chronic critical leg ischaemia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design:</h3>\u0000 \u0000 <p>A 5 year follow up study in three hospitals serving a defined population.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting:</h3>\u0000 \u0000 <p>One regional and two district hospitals, Finland.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patients:</h3>\u0000 \u0000 <p>117 Consecutive patients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Outcome measures:</h3>\u0000 \u0000 <p>Survival, amputations, mobility, and care level required.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main results:</h3>\u0000 \u0000 <p>66 Primary reconstructions, 51 primary and 35 later major amputations were done. Preoperatively 27 (53%) of the patients who underwent a primary amputation were in permanent institutional care. Of 86 patients who were living outside an institution, 62 (72%) had a reconstruction. One and five year mortality were 43% and 84% after amputation, and 20% and 57% after reconstruction, respectively. Of the patients who had had an amputation 10% were able to walk and 25% could manage to live outside an institution. Mobility and treatment level after primary and secondary amputations were similar. Forty seven (71%) of the patients who had had a reconstruction did not have an amputation. All patients whose reconstructions were successful preserved their walking ability and independent living.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion:</h3>\u0000 \u0000 <p>To maintain mobility and an independent living in patients with chronic critical leg ischaemia it is necessary to do a reconstruction that can salvage the leg. In old, institutionalised patients chronic critical leg ischaemia is often the harbinger of approaching death and then amputation is the only possible solution. Copyright © 1998 Taylor and Francis Ltd.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100508,"journal":{"name":"European Journal of Surgery","volume":"164 1","pages":"35-43"},"PeriodicalIF":0.0,"publicationDate":"2003-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241598750004931","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20462407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 23
Rectal prolapse and rectal invagination 直肠脱垂和直肠内陷
European Journal of Surgery
Pub Date : 2003-12-02 DOI: 10.1080/110241598750004346
Ridzuan Farouk, Graeme S. Duthie

Solitary rectal ulcer, internal rectal intussusception, and complete rectal prolapse are a range of defaecatory disorders that may have a common aetiology, namely chronic straining. If the pelvic floor is weak, external prolapse is often complicated by faecal incontinence. Few patients, a lack of randomised trials, and difficulties in the interpretation of studies of anorectal physiology (the results of which often seem conflicting) have made the understanding of these disorders difficult. The basis for treatment is clear, however—patients who have symptomatic defaecatory disorders associated with an internal intussusception, or solitary rectal ulcer, or both should have a course of training of pelvic floor muscles, dietary advice, and should use fibre supplements as primary treatment. Operation should be reserved for those patients in whom medical treatment has failed, and it may be expected to relieve symptoms in above two thirds of patients. Defaecating proctography may be useful in assessing which patients may not benefit from operation. Operation is the primary treatment for external prolapse. The choice of surgical approach should be tailored according to the expertise available, the medical condition of the patient, and the presence or absence of pre-existing constipation or incontinence. Copyright © 1998 Taylor and Francis Ltd.

孤立性直肠溃疡、直肠内肠套叠和完全性直肠脱垂是一系列排便疾病，它们可能有一个共同的病因，即慢性紧张。如果盆底虚弱，外脱垂常并发大便失禁。患者少，缺乏随机试验，以及解释肛肠生理学研究的困难(其结果似乎经常相互矛盾)使得对这些疾病的理解变得困难。然而，治疗的基础是明确的——患有伴有肠套叠或孤立性直肠溃疡的症状性排便障碍的患者，或两者兼而有之的患者，应进行盆底肌肉训练，饮食建议，并应将纤维补充剂作为主要治疗方法。手术应保留给那些药物治疗失败的病人，并有望缓解三分之二以上病人的症状。排便直肠造影可能有助于评估哪些患者可能无法从手术中获益。手术是治疗外脱垂的主要方法。手术方式的选择应根据现有的专业知识、患者的医疗状况以及是否存在先前存在的便秘或尿失禁进行调整。版权所有©1998 Taylor and Francis Ltd。
{"title":"Rectal prolapse and rectal invagination","authors":"Ridzuan Farouk,&nbsp;Graeme S. Duthie","doi":"10.1080/110241598750004346","DOIUrl":"10.1080/110241598750004346","url":null,"abstract":"<p>Solitary rectal ulcer, internal rectal intussusception, and complete rectal prolapse are a range of defaecatory disorders that may have a common aetiology, namely chronic straining. If the pelvic floor is weak, external prolapse is often complicated by faecal incontinence. Few patients, a lack of randomised trials, and difficulties in the interpretation of studies of anorectal physiology (the results of which often seem conflicting) have made the understanding of these disorders difficult. The basis for treatment is clear, however—patients who have symptomatic defaecatory disorders associated with an internal intussusception, or solitary rectal ulcer, or both should have a course of training of pelvic floor muscles, dietary advice, and should use fibre supplements as primary treatment. Operation should be reserved for those patients in whom medical treatment has failed, and it may be expected to relieve symptoms in above two thirds of patients. Defaecating proctography may be useful in assessing which patients may not benefit from operation. Operation is the primary treatment for external prolapse. The choice of surgical approach should be tailored according to the expertise available, the medical condition of the patient, and the presence or absence of pre-existing constipation or incontinence. Copyright © 1998 Taylor and Francis Ltd.</p>","PeriodicalId":100508,"journal":{"name":"European Journal of Surgery","volume":"164 5","pages":"323-332"},"PeriodicalIF":0.0,"publicationDate":"2003-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241598750004346","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20584529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Symptom criteria do not distinguish between functional and organic dyspepsia 症状标准不能区分功能性消化不良和器质性消化不良
European Journal of Surgery
Pub Date : 2003-12-02 DOI: 10.1080/110241598750004373
Per Lundquist, Rein Seensalu, Bengt Lindén, Lars H. Nilsson, Greger Lindberg

Design:

Retrospective study.

Setting:

Teaching hospital, Sweden.

Objective:

To find out if various diagnostic criteria could distinguish organic from non-organic causes of dyspepsia.

Subjects:

635 patients previously interviewed by computer questionnaire.

Interventions:

Upper gastrointestinal endoscopy, laboratory tests, clinical examination.

Main outcome measure:

Differentiation between organic and functional dyspepsia.

Results:

106 patients had functional dyspepsia. Of these 83 had ulcer-like dyspepsia, 76 motility-like dyspepsia, and 50 reflux-like dyspepsia. Eight patients had unspecified dyspepsia.

Conclusions:

There was a considerable overlap between different subgroups, and the criteria did not differentiate between organic and non-organic causes of dyspepsia though the symptom criteria in most cases showed an independent value in discriminating between different subgroups. The clinical usefulness of the criteria remains to be shown. Copyright © 1998 Taylor and Francis Ltd.

设计:回顾性研究。地点:瑞典教学医院。目的:探讨各种诊断标准能否区分消化不良的器质性与非器质性病因。对象:635例既往电脑问卷调查患者。干预措施:上消化道内镜检查、实验室检查、临床检查。主要观察指标:器质性消化不良与功能性消化不良的区分。结果:106例患者出现功能性消化不良。其中83例为溃疡样消化不良，76例为动力样消化不良，50例为反流样消化不良。8例患者有不明原因的消化不良。结论:不同亚组之间存在相当大的重叠，尽管大多数情况下症状标准在区分不同亚组时具有独立的价值，但该标准并不能区分消化不良的器质性原因和非器质性原因。该标准的临床实用性仍有待证实。版权所有©1998 Taylor and Francis Ltd。
{"title":"Symptom criteria do not distinguish between functional and organic dyspepsia","authors":"Per Lundquist,&nbsp;Rein Seensalu,&nbsp;Bengt Lindén,&nbsp;Lars H. Nilsson,&nbsp;Greger Lindberg","doi":"10.1080/110241598750004373","DOIUrl":"10.1080/110241598750004373","url":null,"abstract":"<div>\u0000 \u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Design:</h3>\u0000 \u0000 <p>Retrospective study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting:</h3>\u0000 \u0000 <p>Teaching hospital, Sweden.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective:</h3>\u0000 \u0000 <p>To find out if various diagnostic criteria could distinguish organic from non-organic causes of dyspepsia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Subjects:</h3>\u0000 \u0000 <p>635 patients previously interviewed by computer questionnaire.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interventions:</h3>\u0000 \u0000 <p>Upper gastrointestinal endoscopy, laboratory tests, clinical examination.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main outcome measure:</h3>\u0000 \u0000 <p>Differentiation between organic and functional dyspepsia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results:</h3>\u0000 \u0000 <p>106 patients had functional dyspepsia. Of these 83 had ulcer-like dyspepsia, 76 motility-like dyspepsia, and 50 reflux-like dyspepsia. Eight patients had unspecified dyspepsia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions:</h3>\u0000 \u0000 <p>There was a considerable overlap between different subgroups, and the criteria did not differentiate between organic and non-organic causes of dyspepsia though the symptom criteria in most cases showed an independent value in discriminating between different subgroups. The clinical usefulness of the criteria remains to be shown. Copyright © 1998 Taylor and Francis Ltd.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100508,"journal":{"name":"European Journal of Surgery","volume":"164 5","pages":"345-352"},"PeriodicalIF":0.0,"publicationDate":"2003-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241598750004373","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20585060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma: a multivariate analysis of 76 cases 76例原发性胃肠道非霍奇金淋巴瘤预后因素分析
European Journal of Surgery
Pub Date : 2003-12-02 DOI: 10.1080/110241598750004427
F. Sanchez-Bueno, J. A. Garcia-Marcilla, J. D. Alonso, J. Acosta, L. Carrasco, A. Piñero, P. Parrilla

Objective:

To present our experience with the treatment of primary gastrointestinal (GI) non-Hodgkin's lymphoma, evaluate prognostic factors, and give our recommendations for treatment.

Design:

Retrospective study.

Setting:

Teaching hospital, Spain.

Subjects:

76 patients (47 men and 29 women, mean age 51 years) treated over the 15 years 1980–1994.

Interventions:

52 patients had radical resections, 19 palliative resections, and 5 biopsy alone. 42 (55%) also had adjuvant chemotherapy and 20 (26%) radiotherapy.

Results:

Patients with primary intestinal lymphoma were slightly but not significantly younger than those with gastric lymphoma (43 compared with 56 years). 43 Patients (57%) had tumours in the stomach, 26 (34%) in the small bowel, and 7 (9%) in the colon. At presentation 34 had stage I disease, 25 stage IIE1 disease, and the remaining 17 stage IIE2; 14 were classified as low grade, 41 as intermediate, and 21 as high grade. 60 (79%) had a B-cell phenotype. Overall 5-year survival was 53%. Of the 11 variables tested by univariate analysis for their prognostic effect only abdominal mass (p < 0.001), clinical stage (p < 0.001), type of operation (p < 0.001), tumour size (p < 0.05), and histological grade (p < 0.05) achieved significance, but when Cox's multivariate analysis was applied only clinical stage was significant (p < 0.01).

Conclusion:

Operation is the treatment of choice, but chemotherapy and radiotherapy may have a role though as yet there are no standard guidelines for their use. Copyright © 1998 Taylor and Francis Ltd.

目的:介绍我们治疗原发性胃肠道(GI)非霍奇金淋巴瘤的经验，评估预后因素，并给出我们的治疗建议。设计:回顾性研究。地点:西班牙教学医院。对象:76例患者(男性47例，女性29例，平均年龄51岁)于1980-1994年间接受治疗。干预措施:根治性切除52例，姑息性切除19例，单独活检5例。42例(55%)接受了辅助化疗，20例(26%)接受了放疗。结果:原发性肠淋巴瘤患者比胃淋巴瘤患者年轻(43岁比56岁)，但不明显。43例(57%)胃肿瘤，26例(34%)小肠肿瘤，7例(9%)结肠肿瘤。入院时34例为I期，25例为IIE1期，其余17例为IIE2期;14个为低等级，41个为中等等级，21个为高等级。60例(79%)为b细胞表型。总体5年生存率为53%。单因素分析对预后影响的11个变量中，只有腹部肿块(p <0.001)，临床分期(p <0.001)，操作类型(p <0.001)，肿瘤大小(p <0.05)，组织学分级(p <0.05)达到显著性，但应用Cox多因素分析时，只有临床分期具有显著性(p <0.01)。结论:手术是治疗的首选，但化疗和放疗可能有一定作用，但目前尚无标准的使用指南。版权所有©1998 Taylor and Francis Ltd。
{"title":"Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma: a multivariate analysis of 76 cases","authors":"F. Sanchez-Bueno,&nbsp;J. A. Garcia-Marcilla,&nbsp;J. D. Alonso,&nbsp;J. Acosta,&nbsp;L. Carrasco,&nbsp;A. Piñero,&nbsp;P. Parrilla","doi":"10.1080/110241598750004427","DOIUrl":"10.1080/110241598750004427","url":null,"abstract":"<div>\u0000 \u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective:</h3>\u0000 \u0000 <p>To present our experience with the treatment of primary gastrointestinal (GI) non-Hodgkin's lymphoma, evaluate prognostic factors, and give our recommendations for treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design:</h3>\u0000 \u0000 <p>Retrospective study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting:</h3>\u0000 \u0000 <p>Teaching hospital, Spain.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Subjects:</h3>\u0000 \u0000 <p>76 patients (47 men and 29 women, mean age 51 years) treated over the 15 years 1980–1994.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interventions:</h3>\u0000 \u0000 <p>52 patients had radical resections, 19 palliative resections, and 5 biopsy alone. 42 (55%) also had adjuvant chemotherapy and 20 (26%) radiotherapy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results:</h3>\u0000 \u0000 <p>Patients with primary intestinal lymphoma were slightly but not significantly younger than those with gastric lymphoma (43 compared with 56 years). 43 Patients (57%) had tumours in the stomach, 26 (34%) in the small bowel, and 7 (9%) in the colon. At presentation 34 had stage I disease, 25 stage IIE1 disease, and the remaining 17 stage IIE2; 14 were classified as low grade, 41 as intermediate, and 21 as high grade. 60 (79%) had a B-cell phenotype. Overall 5-year survival was 53%. Of the 11 variables tested by univariate analysis for their prognostic effect only abdominal mass (<i>p</i> &lt; 0.001), clinical stage (<i>p</i> &lt; 0.001), type of operation (<i>p</i> &lt; 0.001), tumour size (<i>p</i> &lt; 0.05), and histological grade (<i>p</i> &lt; 0.05) achieved significance, but when Cox's multivariate analysis was applied only clinical stage was significant (<i>p</i> &lt; 0.01).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion:</h3>\u0000 \u0000 <p>Operation is the treatment of choice, but chemotherapy and radiotherapy may have a role though as yet there are no standard guidelines for their use. Copyright © 1998 Taylor and Francis Ltd.</p>\u0000 </section>\u0000 </div>","PeriodicalId":100508,"journal":{"name":"European Journal of Surgery","volume":"164 5","pages":"385-392"},"PeriodicalIF":0.0,"publicationDate":"2003-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241598750004427","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20585065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Invited commentary 请评论
European Journal of Surgery
Pub Date : 2003-12-02 DOI: 10.1080/110241598750005921
Lars Påhlman
{"title":"Invited commentary","authors":"Lars Påhlman","doi":"10.1080/110241598750005921","DOIUrl":"https://doi.org/10.1080/110241598750005921","url":null,"abstract":"","PeriodicalId":100508,"journal":{"name":"European Journal of Surgery","volume":"164 7","pages":"541-542"},"PeriodicalIF":0.0,"publicationDate":"2003-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241598750005921","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"109160981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anton N. Sidawy, Bauer E. Sumpio, Ralph G. DePalma (Eds): The basic science of vascular disease. Futura Publishing Company Inc; Armonk, New York. 1997. (900 pages). ISBN 0-87993-627-4 Anton N. Sidawy, Bauer E. Sumpio, Ralph G. DePalma(主编):血管疾病的基础科学。Futura出版公司;阿蒙克，纽约，1997。(900页)。ISBN 0-87993-627-4
European Journal of Surgery
Pub Date : 2003-12-02 DOI: 10.1080/110241598750004571
Anders G. Olsson
{"title":"Anton N. Sidawy, Bauer E. Sumpio, Ralph G. DePalma (Eds): The basic science of vascular disease. Futura Publishing Company Inc; Armonk, New York. 1997. (900 pages). ISBN 0-87993-627-4","authors":"Anders G. Olsson","doi":"10.1080/110241598750004571","DOIUrl":"10.1080/110241598750004571","url":null,"abstract":"","PeriodicalId":100508,"journal":{"name":"European Journal of Surgery","volume":"164 4","pages":"317"},"PeriodicalIF":0.0,"publicationDate":"2003-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/110241598750004571","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81511364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
European Journal of Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1